Carvedilol for heart failure: More than just a beta-blocker?

British Journal of Hospital Medicine

Volumn 58, Issue 10, 1997, Pages 493-497

  Cleland, John G F ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAZOLE DERIVATIVE; CARVEDILOL; PROPANOLAMINE DERIVATIVE;

AGED; ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY DISEASE; DRUG EFFECT; EXERCISE TEST; FEMALE; HEART LEFT VENTRICLE FUNCTION; HUMAN; MALE; MIDDLE AGED; MORBIDITY; MORTALITY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL;

ADRENERGIC BETA-ANTAGONISTS; AGED; CARBAZOLES; CORONARY DISEASE; EXERCISE TEST; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; MORBIDITY; PROPANOLAMINES; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0031578470     PISSN: 00071064     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Australia-New Zealand Heart Failure Research Collaborative Group (1997) Randomised, placebo-controlled trial of carvedilol m patients with congestive heart failure due to ischaemic heart disease. Lancet 349: 375-80
2. Basu S, Senior R, Raval U, van der Does R, Bruckner T, Lahiri A (1997) Beneficial effects of intravenous and oral carvedilol treatment m acute mvocardial infarction: a placebo-controlled, randomized trial. Circulation 96: 183-91
3. Bristow MR, Hershberger RE, Port ID et al (1990) β-adrenergic pathways in nonfaihng and failing human ventricular myocardium. Circulation 82: 12-25
4. Bristow MR, Gilbert EM, Abraham WT et al for the MOCHA Investigators (1996) Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. Circulation 94: 2807-16
5. CIBIS Investigators and Committees (1994) A randomized trial of -blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation 90: 1765-73
6. Cleland JGF (1995) ACE inhibitors for the prevention and treatment of heart failure. Why aren't they 'under-used'? J Hum Hypenens 9: 435-42
7. Cleland JGF, Oakley CM (1991) Vascular tone in heart failure: the neuroendocnne-therapeutic interface. Br Heart J 66: 264-7
8. Cleland JGF, Swedberg K (1996) Carvedilol for heart failure, with care. Lancet 347: 1199-201
9. Cleland JGF, Ray SG, McMurray JJV (1994) Prevention Strategies after Myocardial Infarction. Science Press, London
10. Cleland JGF, Bristow M, Erdmann E, Remme WJ, Swedberg K, Waagstein F (1996) Beta-blocking agents in heart failure. Should they be used and how? Eur Heart] 17: 1629-39
11. Epstein SE, Braunwald E (1966) The effect of beta-adrenergic blockade on patterns of urinary sodium excretion. Ann Intern Med 65: 20-7
12. Gilbert EM, Olsen SL, Renlund DG, Bristow MR (1993) Betaadrenergic receptor regulation and left ventricle function m idiopathic dilated cardiomyopathy. Am] Cardiol 71: 23c-29c
13. Hall SA, Cigarroa CG, Marcoux L, Risser RC, Grayburn PA, Eichhorn El (1995) Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade./ Am Coll Cardiol 25: 1154-61
14. Packer M, Bristow MR, Cohn JN et al for the US carvedilol study group (1996) The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Mol 334:1349-55
15. Sackner-Bernstein J, Krum H, Goldsmith RL et al (1995) Should worsening heart failure early after initiation of betablocker therapy for chronic heart failure preclude longterm treatment? Circulation 92 (Suppl I): 1-395 (abstract)
16. SOEVD Investigators (1991) Effect of enalapnl on survival m patients with reduced left ventricular ejection fractions and congestive heart failure. N EnglJ Med 325: 293-302
17. Swedberg K, for the CONSENSUS trial study group (1987) Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N En&l ] Med 316:1429-35
18. Swedberg K, Hjalmarson A, Waagstein F, Wallentin I (1979) Prolongation of survival in congestive eardiomyopathy by beta-receptor blockade. Lancet i: 1364-6
19. Swedberg K, Hjalmarson A, Waagstein F et al (1980) Adverse effects of beta-blockade withdrawal in patients with congestive cardiomyopathy. Br Heart] 44: 134-42
20. Waagstein F, Hjalmarson A, Wasir HS (1974) Apex cardiogram and systolic time intervals in acute myocardial infarction and effect of practolol. Br Heart J 36: 1109-121
21. Waagstein F, Bristow MR, Swedberg K et al (1993) Beneficial effect of metoprolol in idiopathic dilated cardiomyopathy. Lancet 342: 1441-6
22. Yusuf S (1991) Effect of enalapnl on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N EnglJ Med 325: 293-302